Literature DB >> 15868494

Treatment of pilonidal sinus by phenol application and factors affecting the recurrence.

N Kaymakcioglu1, G Yagci, A Simsek, A Unlu, O F Tekin, S Cetiner, T Tufan.   

Abstract

BACKGROUND: Phenol injection, a less invasive method, has become more popular for the treatment of sinus pilonidalis. Recurrence rates after the use of phenol have been reported to be less than those after other surgical methods.
METHODS: In this study, we applied 80% phenol to 143 patients with sinus pilonidalis. Patients were reevaluated at 1, 3, 6, 12 and 24 months after the phenolization procedure to search for any recurrences. Age, sex, skin color, occupation, hair distribution, complaints, macroscopic characteristics of the lesion, pouch volume, microbiological yield, complications of phenol injection, healing time, and recurrences were determined.
RESULTS: The mean follow-up period was 24 months and the recurrence rate was 8.3% (12 of 143 patients). Volume of the sinus tract and number of sinus orifices were determined to be the factors significantly affecting recurrences (p<0.05).
CONCLUSIONS: Injection of 80% phenol is an ideal approach for the conservative treatment of sinus pilonidalis. This study confirms that this is an effective and costless method with low recurrence rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868494     DOI: 10.1007/s10151-005-0187-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  29 in total

Review 1.  Review of phenol treatment in sacrococcygeal pilonidal disease.

Authors:  Cuneyt Kayaalp; Cemalettin Aydin
Journal:  Tech Coloproctol       Date:  2009-08-05       Impact factor: 3.781

2.  Comparison of Karydakis flap reconstruction versus primary midline closure in sacrococcygeal pilonidal disease: results of 200 military service members.

Authors:  Mehmet Fatih Can; Mert Mahsuni Sevinc; Mehmet Yilmaz
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

3.  Volume of the excised specimen and prediction of surgical site infection in pilonidal sinus procedures (surgical site infection after pilonidal sinus surgery).

Authors:  Husnu Alptekin; Huseyin Yilmaz; Seyit Ali Kayis; Mustafa Sahin
Journal:  Surg Today       Date:  2012-12-09       Impact factor: 2.549

4.  The results of a one-time crystallized phenol application for pilonidal sinus disease.

Authors:  Mustafa Girgin; Burhan Hakan Kanat
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

Review 5.  German national guideline on the management of pilonidal disease.

Authors:  I Iesalnieks; A Ommer; S Petersen; D Doll; A Herold
Journal:  Langenbecks Arch Surg       Date:  2016-06-16       Impact factor: 3.445

6.  Treatment of pilonidal disease by combination of pit excision and phenol application.

Authors:  A Olmez; C Kayaalp; C Aydin
Journal:  Tech Coloproctol       Date:  2012-09-28       Impact factor: 3.781

7.  Minimally invasive treatment of pilonidal disease: crystallized phenol and laser depilation.

Authors:  Mustafa Girgin; Burhan Hakan Kanat; Refik Ayten; Ziya Cetinkaya; Zekiye Kanat; Ahmet Bozdağ; Ahmet Turkoglu; Yavuz Selim Ilhan
Journal:  Int Surg       Date:  2012 Oct-Dec

8.  Crystallized phenol treatment of pilonidal disease improves quality of life.

Authors:  Omer Topuz; Selim Sözen; Mustafa Tükenmez; Sezgin Topuz; Umit Erkan Vurdem
Journal:  Indian J Surg       Date:  2012-06-29       Impact factor: 0.656

9.  Recurrent pilonidal disease surgery: Is it second primary or reoperative surgery?

Authors:  Ahmet Deniz Uçar; Erdem Barış Cartı; Erkan Oymacı; Erdem Sarı; Savaş Yakan; Mehmet Yıldırım; Nazif Erkan
Journal:  Ulus Cerrahi Derg       Date:  2015-09-01

10.  Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease.

Authors:  Dietrich Doll; Alexander Novotny; Ronny Rothe; Jette Elisabeth Kristiansen; Kai Wietelmann; Anne-Laure Boulesteix; Wolfgang Düsel; Sven Petersen
Journal:  Int J Colorectal Dis       Date:  2007-10-25       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.